Skip to content

Public FDA record

Z-2044-2023: RelieVR REF: RVX-2002, Rx Only. Virtual reality behavioral therapy device for pain relief.

Recall record Z-2044-2023 for Appliedvr. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-2044-2023
Company in FDA record
Appliedvr
FDA classification date
Jun 30, 2023
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

There is the potential for the program software to malfunction which will not allow it to move forward to the next session.

Source facts

Action
On May, 2, 2023, AppliedVR provided customers with a Medical Device Recall notification in person. The recall notification informed the customer that the device was being recalled. For questions contact AppliedVR or your Health Care Provider.
Initiated
2023-02-27
Root cause
Software Manufacturing/Software Deployment
Distribution
US: NY OUS: None
Recall number
Z-2044-2023
Recall status
Completed
CDRH record ID
200685
FDA classified
2023-06-30
Recall event number
92389

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗